NOMURA ASSET MANAGEMENT CO LTD
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1055964
TOKYO, M0
Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$41,671,564
+$440,585 QoQ
Shares Held
53,934
+1.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90.48966834519881.ToString("F0")%
Shared 0.ToString("F0")%
None 9.510331654801181.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOMURA ASSET MANAGEMENT CO LTD holds $214,904,453 across 68 Biotechnology names. REGN ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
121,167 | $54,105,911 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
53,934 | $41,671,564 | |
| 3 | ARGX |
Argenx SE
|
49,306 | $36,005,704 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,225 | $30,845,354 | |
| 5 | INSM |
INSMED Inc
|
89,660 | $14,661,203 | |
| 6 | ASND |
Ascendis Pharma A/S
|
43,484 | $9,946,095 | |
| 7 | RPRX |
Royalty Pharma plc
|
171,980 | $8,249,880 | |
| 8 | INCY |
Incyte Corp
|
83,320 | $7,842,077 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,671,564 | 53,934 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $41,230,979 | 53,417 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $30,245,064 | 53,791 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,407,350 | 56,014 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $59,168,581 | 93,292 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $65,900,497 | 92,514 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $90,410,842 | 86,004 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $86,506,073 | 82,306 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $72,502,444 | 75,328 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $51,751,479 | 58,923 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $47,307,032 | 57,484 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $40,103,871 | 55,813 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,138,385 | 57,369 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $48,378,067 | 67,053 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $47,678,069 | 69,212 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $43,889,037 | 74,246 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $41,604,877 | 59,570 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $36,472,173 | 57,753 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $32,887,901 | 54,344 | Shares | Sole | 2025-01-10 | |
| 2021-06-30 | $36,964,175 | 66,180 | Shares | Sole | 2025-01-10 | |
| 2021-03-31 | $32,378,389 | 68,433 | Shares | Sole | 2025-01-10 | |
| 2020-12-31 | $28,317,491 | 58,615 | Shares | Sole | 2025-01-10 | |
| 2020-09-30 | $28,734,626 | 51,332 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $30,221,454 | 48,459 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,256,566 | 25,101 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||